Symbol="BTAI"
AssetType="Common Stock"
Name="BioXcel Therapeutics Inc"
Description="BioXcel Therapeutics, Inc., a clinical-phase biopharmaceutical company, focuses on the development of artificial intelligence-based drugs in the fields of neuroscience and immuno-oncology in the United States. The company is headquartered in New Haven, Connecticut."
CIK="1720893"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="555 LONG WHARF DRIVE, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="323088000"
EBITDA="-179032992"
PERatio="None"
PEGRatio="None"
BookValue="1.821"
DividendPerShare="0"
DividendYield="0"
EPS="-6.29"
RevenuePerShareTTM="0.021"
ProfitMargin="0"
OperatingMarginTTM="-308.71"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-1.515"
RevenueTTM="581000"
GrossProfitTTM="355000"
DilutedEPSTTM="-6.29"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="47.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4131.89"
PriceToBookRatio="3.966"
EVToRevenue="2657.94"
EVToEBITDA="-2.748"
Beta="0.84"
num_52WeekHigh="34.12"
num_52WeekLow="5.88"
num_50DayMovingAverage="18.06"
num_200DayMovingAverage="20.18"
SharesOutstanding="29159600"
DividendDate="None"
ExDividendDate="None"
symbol="BTAI"
open="11.33"
high="11.74"
low="10.73"
price="11.08"
volume="1081507.00"
latest_trading_day="2023-07-21"
previous_close="11.23"
change="-0.15"
change_percent="-1.3357%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="69"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="1814613"
Change_recent_avg="-0.08"
Delta_recent_avg="1.57"
Variance_recent_avg="0.79"
Change_ratio_recent_avg="-0.48"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="167"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_negative_thumbnail_id_2="165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="672"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_positive_thumbnail_id_2="687"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
